News Daily News Risk Calculators Miss Many Patients Who Present With First MI Michael O'Riordan November 21, 2025
News Daily News New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again Yael L. Maxwell November 27, 2024
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024
News Daily News Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA Caitlin E. Cox June 25, 2024
News Daily News Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’ Yael L. Maxwell November 08, 2023
News Daily News Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists Todd Neale July 09, 2021
News Daily News ‘Smart’ Approach Wins for Post-PCI Antiplatelet Prescribing Yael L. Maxwell April 19, 2021
News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Daily News Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS Yael L. Maxwell March 25, 2021
News Daily News Superiority of Ticagrelor Over Clopidogrel in ACS Questioned Todd Neale October 29, 2020
News Daily News More Circulating Omega-3s May Boost Prognosis After STEMI Todd Neale October 26, 2020
News Daily News Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published Michael O'Riordan April 27, 2020
News Daily News New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders Yael L. Maxwell March 06, 2020
News Daily News No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry Todd Neale January 15, 2020
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Daily News FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled Michael O'Riordan April 24, 2018
News Daily News Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows Michael O'Riordan September 30, 2016
News Daily News Según un Extenso Análisis Europeo el Uso Actual de FAINE se asocia a un Mayor Riesgo de Insuficiencia Cardíaca Michael O'Riordan September 30, 2016